R&D | April 15, 2026
Regeneron and Telix strike major radiopharma pact in push into next-gen cancer therapies
The companies plan to advance multiple solid tumor targets from Regeneron’s antibody portfolio
The companies plan to advance multiple solid tumor targets from Regeneron’s antibody portfolio
The campaign builds on the three-year partnership unveiled earlier this season
Paves the way for next-gen ultra-precise gas sensing
A major push to sharpen the future of cancer treatment is underway
Scientists at the forum warned of an increasingly volatile health landscape
Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals
Veteran biopharma leader stressed that generic medicines must be viewed separately from biologics
At the centre of this shift is Eli Lilly and Company, whose latest investments in China and Japan are helping redefine the next phase of GLP-1 supply strategy
This event will bring together global stakeholders to explore India’s growing capabilities in pharma and biopharma innovation, research, and manufacturing
MoU aims to strengthen academia-industry collaboration in healthcare research and innovation
Subscribe To Our Newsletter & Stay Updated
